Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ImmunoCellular: Post Hoc Analysis Of Disappointing Phase II Trial Of ICT-107
ImmunoCellular: Post Hoc Analysis Of Disappointing Phase II Trial Of ICT-107
ImmunoCellular: Post Hoc Analysis Of Disappointing Phase II Trial Of ICT-107
Submitted by
admin
on December 16, 2013 - 7:32am
Source:
Seeking Alpha
News Tags:
ICT-107
ImmunoCellular
Northwest Biotherapeutics
Headline:
ImmunoCellular: Post Hoc Analysis Of Disappointing Phase II Trial Of ICT-107
Do Not Allow Advertisers to Use My Personal information
